Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein

The present invention relates, in general, to a method of enhancing the production performance of avians, by administering to a bird a heterologous protein comprised of inhibin protein, or a fragment thereof, and a carrier protein. The present invention also relates to a method of enhancing the production performance of avians, by administering to a bird a fusion gene product comprising a gene encoded for the expression of alpha-subunit avian inhibin protein, or a fragment thereof, and a gene encoded for the expression of a carrier protein. An effective amount of the heterologous protein or fusion gene product is administered to an animal such that an immunological response occurs in the animal against the heterologous protein. The present invention further relates to the above heterologous protein and fusion gene product, and to methods of producing the same.

Skip to:  ·  Claims  ·  References Cited  · Patent History  ·  Patent History

Claims

1. A method which increases egg lay, accelerates onset of egg lay, accelerates onset of maximum egg lay, increases lifetime total egg lay, increases egg production, increases intensity of egg production, prolongs persistence of egg lay, improves egg shell quality, accelerates onset of puberty, accelerates onset of ovulation, prolongs persistence of ovulation, increases sperm production, accelerates onset of sperm production, accelerates onset of maximum sperm production, prolongs persistence of sperm production, improves sperm viability, increases testosterone production, increases ejaculate volume, or increases libido, of a bird, comprising administering an effective mount of a heterologous protein comprising avian alpha-subunit inhibin protein, or an immunogenic fragment thereof, and a carrier protein, to the bird.

2. The method of claim 1, wherein the bird is selected from the group consisting of ratites, psittaciformes, falconiformes, piciformes, strigiformes, passeriformes, coraciformes, ralliformes, cuculiformes, columbiformes, galliformes, anseriformes, and herodiones.

3. The method of claim 2, wherein the ratite is an ostrich, emu, rhea, kiwi, or cassowary.

4. The method of claim 2, wherein the bird is a chicken, turkey, parrot, parakeet, macaw, falcon, eagle, quail, hawk, pigeon, cockatoo, song bird, jay bird, blackbird, finch, warbler, goose, duck, canary, mynah, toucan, or sparrow.

5. The method of claim 1, wherein the carrier protein is maltose binding protein, bovine serum albumin, ovalbumin, flagellin, keyhole-limpet hemocyanin, thyroglobulin, serum albumin, gamma globulin, or polymers of amino acids.

6. The method of claim 1, wherein the bird is a female bird.

7. The method of claim 1, wherein the bird is a male bird.

8. The method of claim 1, wherein the administration of the heterologous protein increases egg production.

9. The method of claim 8, wherein the bird is a quail, turkey, chicken, parrot or ratite.

10. The method of claim 1, wherein the administration of an effective amount of the heterologous protein comprises administration of approximately 0.1 mg to 10.0 mg of heterologous protein to the bird.

11. The method of claim 1, wherein the administration of an effective amount of the heterologous protein comprises administration of approximately 0.1 mg to 6.0 mg of the heterologous protein to the bird.

12. The method of claim 1, further comprising administration of one or more booster injections of approximately 0.05 mg to 5.0 mg of the heterologous protein.

13. The method of claim 1, further comprising administration of one or more booster injections of approximately 0.05 mg to 2.0 mg of the heterologous protein.

14. The method of claim 1, wherein the administration of the heterologous protein occurs before puberty.

15. The method of claim 1, wherein the administration of the heterologous protein occurs during puberty.

16. The method of claim 1, wherein the heterologous protein is a fused heterologous protein.

17. The method of claim 1, wherein the heterologous protein is a conjugated heterologous protein.

18. The method of claim 1, further comprising administration of adjuvants, preservatives, diluents, emulsifiers, or stabilizers.

19. The method of claim 1, wherein the administration occurs after puberty.

20. The method of claim 1, wherein the avian alpha-subunit inhibin protein, or an immunogenic fragment thereof, comprises the amino acid sequence set forth in SEQ ID NO:2.

Referenced Cited
U.S. Patent Documents
4864019 September 5, 1989 Vale et al.
5089396 February 18, 1992 Mason et al.
5102807 April 7, 1992 Burger et al.
Foreign Patent Documents
WO 95/22980 August 1995 WOX
Other references
  • Daniel et al. Virology 202:540-549, 1994. "Synthetic Peptide Segments of Inhibin .alpha.-and .beta.-Subunits: Preparation and Characterization of Polyclonal Antibodies", Saito et al., Endocrinology, 1989, vol. 125, No.2, pp. 898-905. Murdoch, W.J., "Immunoregulation of mammalian fertility," Life Sci., vol. 55 (24), pp. 1871-1886 (1994). Forage, R.G. et al., "Immunization against an inhibin subunit produced by recombinant DNA techniques results in increased ovulation rate in sheep," J. Endocrinol., vol. 114 (2), p. R1-4 (Aug. 1987). Morris, D.G. et al., "Effect of immunization against synthetic peptide sequences of the alpha N-subunit of bovine inhibin on ovulation rate, gonadotrophin concentrations and fertility in heifers," J. Reprod. Fertil., vol. 103 (2), pp. 285-291 (Mar. 1995). Bowie et al. 1990. Science 247-1306-1310. Fraser et al., "Does inhibin have an endocrine role during the luteal phase of the primate menstrual cycle?", Journal of Reproduction and Fertility, No. 11, Abstract No. 78 (Jul. 1993). Webley et al., "Inverse relationship between progesterone and inhibin .alpha.-subunit production by marmoset luteal cells in vitro", Journal of Reproduction and Fertility, No. 11, Abstract No. 155 (Jul. 1993). Morris et al., "Effect of immunization against bovine inhibin peptides on FSH and LH in heifers", Journal of Reproduction and Fertility, No. 11, Abstract No. 156 (Jul. 1993). Rivier et al., "Studies of the Inhibin Family of Hormones: A Review", Hormone Res., vol. 28, pp. 104-118 (1987). Akashiba et al., "Secretion of Inhibin by Chicken Granulosa Cells in vitro", Poultry Science, vol. 67, pp. 1625-1631 (1988). Findlay, "An Update on the Roles of Inhibin, Activin, and Follistatin as Local Regulators of Folliculogenesis", Biology of Reproduction, vol. 48, pp. 15-23 (1993). Johnson et al., "The molecular biology and endocrinology of inhibin in the domestic hen", Journal of Endocrinology, pp. 297-308, (1993). Johnson et al., "Characterization of a Source and Levels of Plasma Immunoreactive Inhibin during the Ovulatory Cycle of the Domestic Hen", Biology of Reproduction, vol. 48, pp. 262-267 (1993). Johnson et al., "Characterization and Quantitation of mRNA for the Inhibin .alpha.-Subunit in the Granulosa Layer of the Domestic Hen", General and Comparative Endocrinology, vol. 90, pp. 43-50 (1993). Johnson et al., "Plasma Concentrations of Immunoeractive Inhibin and Gonadotropins following Removal of Ovarian Follicles in the Domestic Hen", Biology of Reproduction, vol. 49, pp. 1-6 (1993). McNatty et al., "Contrations of immunoreactive inhibin in ovarian and peripheral venous plasma and follicular fluid of Booroola ewes that are homozygous carriers or non-carriers of the Fec.sup.B gene", J. Reprod. Fert., vol. 95, pp. 489-502 (1992). Rivier et al., "Age-Dependent Changes in Physiological Action, Content, and Immunostaining of Inhibin in Male Rates", Endocrinology, vol. 123, pp. 120-126 (1988). Robertson et al., "Isolation of a 31 kDa form of inhibin from bovine follicular fluid", Molecular and Cellular Endocrinology, vol. 44, pp. 271-277 (1986). Scanlong et al., "Active immunization of heifers against a synthetic fragment of bovinc inhibin", Journal of Reproduction and Fertility, vol. 97, pp. 213-222 (1993). Tsonis et al., "Inhibin bioactivity and pituitary cell mitogenic activity from cultured chicken ovarian granulosa and thecal/stromal cells", Journal of Endocrinology, vol. 116, pp. 293-299 (1988). Glencross et al., "Effect of active immunization of heifers against inhibin on plasma FSH concentrations, ovarian follicular development and ovulation rate", Journal of Endocrinology, vol. 135, pp. 11-18 (1992). Johnson, "Inhibin in the Hen", Poultry Sciences, vol. 72, pp. 955-958 (1993). Meyer et al., "Antiserum to an inhibin alpha-chain peptide neutralizes inhibin bioactivity and increases ovulation rate in sheep", J. Anim. Science, vol. 69, pp. 747-754 (1991). Morris et al., "Effect of immunizing prepuberal lambs of low and high ovulation rate genotypes with inhibin partially purified from bovine follicular fluid", Theriogeneology, vol. 35, No. 2, pp. 339-350 (Feb. 1991). Morris et al., "Effect of immunization against synthetic peptide sequences of bovine inhibin .alpha.-subunit on ovulation rate and twin-calving rate in heifers", Journal of Reproduction and Fertility, vol. 97, pp. 255-261 (1993). Risridger et al., "Current perspectives of inhibin biology", Acta Endocrinologica (Copenh), vol. 122 pp. 673-682 (1990). Wang et al., "Increase in Ovarian .alpha.-Inhibin Gene Expression and Plasma Immunoeractive Inhibin Level Is Correlated with a Decrease in Ovulation Rate in the Domestic Hen", General and Comparative Endocrinology, vol. 91, pp. 52-58 (1993). Wang et al., "Complementary Deoxyribonucleic Acid Cloning and Sequence Analysis of the .alpha.-Subunit of Inhibin from Chicken Ovarian Granulosa Cells", Biology of Reproduction, vol. 49, pp. 1-6 (1993). Wrathall et al., "Effects of active immunization against a synthetic peptide sequence of the inhibin .alpha.-subunit on plasma gonadotrophin concentrations, ovulation rate and lambing rate in ewes", J. Reprod. Fert., vol. 95, pp. 175-182 (1992). North et al., "Flock Recycling", Commercial Chicken Production Manual, Van Nostrand Reinhold, New york, pp. 434-439 (date unknown). Chinnah et al., "Antigen dependent adjuncant activity of a polydispersed .alpha.-(1-4)-linked acetylated mannan (acemannan)", vaccine, vol. 10(8), pp. 551-557 (1992). Chouljenko et al., "Expression and Purification of Chicken and Inhibition as a Fusion Protein with the E.Coli Maltose Binding Protein," Poultry Science, vol. 73 (Suppl. 1), p. 84 (1994).
Patent History
Patent number: 5725858
Type: Grant
Filed: Jun 7, 1995
Date of Patent: Mar 10, 1998
Assignees: Agritech Technologies, Ltd. (Grand Prairie, TX), Board of Supervisors of Louisiana State Univ. and Agricultural & Mechanical College (Baton Rouge, LA)
Inventors: William C. Fioretti (Colleyville, TX), Konstantin Kousoulas (Baton Route, LA), Daniel G. Satterlee (Prairieville, LA)
Primary Examiner: David L. Fitzgerald
Assistant Examiner: Elizabeth C. Kemmerer
Law Firm: Jones & Askew
Application Number: 8/481,633
Classifications
Current U.S. Class: 424/1921; 424/1841; 424/1851; 424/1931; 424/19511; 424/1981; 514/2; 514/8; 514/12
International Classification: A61K 3816; A61K 3802;